Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2664-2669

  Umemura, Kazuo ^a   Ikeda, Yasuhiko ^a   Kondo, Kazunao ^a   Nakashima, Mitsuyoshi ^a   Naganuma, Hideo ^b   Hisaoka, Masafumi ^b   Nishino, Hiroshi ^c   Tajima, Masazo ^c  

^a HAMAMATSU UNIVERSITY   (Japan)

^b Research Institute of Sankyo   (Japan)

^c Sankyo Clin Development Department   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBAPENEM DERIVATIVE; PROBENECID; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERANCE; ENZYME BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030862235     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2664     Document Type: Article

References (7)

1. Efthymiopoulos, C., A. Capriati, P. Barrington, J. Patel, E. V. B. Shenoy, and A. Bye. 1994. Pharmacokinetics of GV104326, a novel tribactam antibiotic, following single intravenous and oral (as its prodrug GV 118819X) administration in man, abstr. F82, p. 129. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
2. Holme, E., J. Greter, C.-E. Jacobson, S. Lindstedt, I. Nordin, B. Kristiansson, and U. Jodal. 1989. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 8661:469-473.
3. Kawamoto, I., M. Miyauchi, R. Endo, M. Hisaoka, H. Yasuda, and S. Kuwahara. 1996. CS-834, a new oral carbapenem. I. Structure-activity relationships of 2-substituted 1b-methylcarbapenems, abstr. F105, p. 118. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Nakagawa, A., A. Shigeta, N. Watanabe, S. Muramatsu, H. Naganuma, K. Kunisada, M. Hisaoka, S. Manabe, and S. Kuwahara. 1996. CS-834, a new oral carbapenem. IV. Pharmacokinetics, metabolism and safety in laboratory animals, abstr. F108, p. 118. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Nakashima, M., T. Uematsu, T. Oguma, T. Yoshida, K. Mizojiri, S. Matsuno, and S. Yamamoto. 1992. Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores. Antimicrob. Agents Chemother. 36:762-768.
6. Sjövall, J., G. Alvan, and D. Westerlund. 1985. Dose-dependent absorption of amoxycillin and bacampicillin. Clin. Pharmacol. Ther. 38:241-250.
7. Utsui, Y., T. Takenouchi, N. Masuda, H. Domon, M. Kakuta, C. Ishii, C. Ishii, E. Sakagawa, T. Abe, S. Ohya, H. Yasuda, M. Iwata, and S. Kuwahara. 1996. CS-834, a new oral carbapenem. II. In vitro evaluation of R-95867, the active metabolite of CS-834, abstr. F106, p. 118. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.